Cyclosporin A induces erythroid differentiation of K562 cells through p38 MAPK and ERK pathways. 2003

Kanoko Sawafuji, and Yoshitaka Miyakawa, and Masahiro Kizaki, and Yasuo Ikeda
Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.

We studied the effects of cyclosporin A (CsA) on the erythroid differentiation of human erythroid leukemia cell line K562. After K562 was treated with CsA for 4 days, the percentage of hemoglobinized cells was increased by 3.3 times. Because it was reported p38 MAPK (p38) and ERK are involved in erythropoietin-induced erythroid differentiation, we studied their roles using specific inhibitors. p38 inhibitor (SB203580) prevented CsA-induced hemoglobin synthesis in K562 cells, although MEK/ERK inhibitor (U0126) enhanced it by 3.3 times in K562 cells. These results indicate activation of p38 and inactivation of ERK are involved in CsA-induced erythroid differentiation of K562 cells.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009570 Nitriles Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE. Nitrile
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D002070 Butadienes Four carbon unsaturated hydrocarbons containing two double bonds. Butadiene Derivative,Butadiene Derivatives,Derivative, Butadiene,Derivatives, Butadiene
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006454 Hemoglobins The oxygen-carrying proteins of ERYTHROCYTES. They are found in all vertebrates and some invertebrates. The number of globin subunits in the hemoglobin quaternary structure differs between species. Structures range from monomeric to a variety of multimeric arrangements. Eryhem,Ferrous Hemoglobin,Hemoglobin,Hemoglobin, Ferrous
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Kanoko Sawafuji, and Yoshitaka Miyakawa, and Masahiro Kizaki, and Yasuo Ikeda
August 2012, Molecular and cellular biochemistry,
Kanoko Sawafuji, and Yoshitaka Miyakawa, and Masahiro Kizaki, and Yasuo Ikeda
November 2004, Leukemia,
Kanoko Sawafuji, and Yoshitaka Miyakawa, and Masahiro Kizaki, and Yasuo Ikeda
April 2000, Blood,
Kanoko Sawafuji, and Yoshitaka Miyakawa, and Masahiro Kizaki, and Yasuo Ikeda
March 2004, Journal of cellular physiology,
Kanoko Sawafuji, and Yoshitaka Miyakawa, and Masahiro Kizaki, and Yasuo Ikeda
February 2015, Cytokine,
Kanoko Sawafuji, and Yoshitaka Miyakawa, and Masahiro Kizaki, and Yasuo Ikeda
April 2001, Experimental cell research,
Kanoko Sawafuji, and Yoshitaka Miyakawa, and Masahiro Kizaki, and Yasuo Ikeda
January 2011, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology,
Kanoko Sawafuji, and Yoshitaka Miyakawa, and Masahiro Kizaki, and Yasuo Ikeda
April 2018, Toxins,
Kanoko Sawafuji, and Yoshitaka Miyakawa, and Masahiro Kizaki, and Yasuo Ikeda
January 2012, International journal of molecular sciences,
Kanoko Sawafuji, and Yoshitaka Miyakawa, and Masahiro Kizaki, and Yasuo Ikeda
April 2004, Anti-cancer drugs,
Copied contents to your clipboard!